FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

4828011000036104: Karvezide 300/25 (hydrochlorothiazide 25 mg + irbesartan 300 mg) tablet (trade product unit of use)

Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
187536011000036114 Karvezide 300/25 (hydrochlorothiazide 25 mg + irbesartan 300 mg) film-coated tablet (trade product unit of use) en Fully specified name Inactive Case sensitive Australian Medicines Terminology module
187538011000036113 Karvezide 300/25 film-coated tablet en Synonym Inactive Case sensitive Australian Medicines Terminology module
3632651000168113 Karvezide 300/25 (hydrochlorothiazide 25 mg + irbesartan 300 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3632661000168110 Karvezide 300/25 tablet en Synonym Active Case sensitive Australian Medicines Terminology module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Karvezide 300/25 tablet has manufactured dose form tablet true Inferred relationship Some
Karvezide 300/25 tablet has Australian BoSS hydrochlorothiazide true Inferred relationship Some 457169854
Karvezide 300/25 tablet has unit of use tablet true Inferred relationship Some 1796630765
Karvezide 300/25 tablet Is a trade product unit of use true Inferred relationship Some
Karvezide 300/25 tablet Is a Karvezide 300/25 true Inferred relationship Some
Karvezide 300/25 tablet Is a irbesartan 300 mg + hydrochlorothiazide 25 mg tablet true Inferred relationship Some
Karvezide 300/25 tablet has manufactured dose form film-coated tablet false Inferred relationship Some
Karvezide 300/25 tablet has intended active ingredient irbesartan true Inferred relationship Some 1796630764
Karvezide 300/25 tablet has Australian BoSS irbesartan true Inferred relationship Some 1796630764
Karvezide 300/25 tablet has intended active ingredient hydrochlorothiazide true Inferred relationship Some 457169854
Inbound Relationships Type Active Source Characteristic Refinability Group
Karvezide 300/25 tablet, 30 has TPUU True Karvezide 300/25 tablet Inferred relationship Some 1
Karvezide 300/25 tablet, 30, blister pack has TPUU True Karvezide 300/25 tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start